We are de-risking and accelerating drug discovery by combining quantum and AI. As an AI/Biotech hybrid, we are using a novel approach to generate better enzyme inhibitors. Our uniquely positioned, proprietary, discovery platform addresses key liabilities such as specificity, potency, and resistance.